- 22nd Century Group (XXII +2%) closed an investment in Panacea Life Sciences, a developer and producer of legal, THC-free, hemp-derived cannabinoid products.
- 22nd Century’s investments in Panacea over the next 12 -18 months are expected to total $24M.
- The company also received a warrant to purchase preferred stock of Panacea, which upon full exercise will provide 22nd Century with a controlling equity position in Panacea.
22nd Century Group invests in Panacea Life Sciences
Recommended For You
About XXII Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
XXII | - | - |
22nd Century Group, Inc. |